Oral Micronized Progesterone Cost in New Mexico 2026

What Does Oral Micronized Progesterone Cost in New Mexico Right Now?

The cash price you pay depends almost entirely on which product and which pharmacy you choose. Brand-name Prometrium carries a manufacturer list price of roughly $180 per month in 2026. Generic oral micronized progesterone at major New Mexico retail chains averages about $45 per month when purchased with a free discount card such as GoodRx or RxSaver. Compounded versions from a licensed New Mexico 503A pharmacy drop that figure further, to approximately $25 per month for a standard 100 mg nightly supply.

Brand vs. Generic: The Price Gap

Prometrium (progesterone USP in peanut oil, manufactured by Abbvie/Allergan) was first approved by the FDA under NDA 020843 for secondary amenorrhea and endometrial protection in postmenopausal women on estrogen therapy. The full prescribing information is maintained on FDA's accessdata portal.

Generic oral micronized progesterone entered the U.S. Market after patent expiration and now accounts for the majority of prescriptions written. At Walgreens, CVS, Smith's (Kroger), and Walmart Pharmacy locations across Albuquerque, Santa Fe, and Las Cruces, the 100 mg capsule in a 30-count supply typically prices at $40 to $55 cash before any coupon. The 200 mg capsule for cyclic use runs slightly higher, around $55 to $75 per 30-count.

Discount Cards and Coupons in New Mexico

Free pharmacy discount programs can reduce the generic price substantially. GoodRx routinely shows prices below $20 for a 30-count supply of 100 mg generic progesterone at select New Mexico locations. These cards are not insurance and cannot be combined with Medicaid or Medicare Part D at the point of sale, but they are legally available to any cash-pay patient.

The Abbvie manufacturer savings card for brand Prometrium may reduce out-of-pocket cost for commercially insured patients to as low as $0 per fill, subject to eligibility and annual maximum limits. Patients without insurance do not qualify for the manufacturer card. Terms change annually; always verify at the manufacturer's patient support line.

Does New Mexico Medicaid Cover Oral Micronized Progesterone?

New Mexico Medicaid (Centennial Care) does not cover oral micronized progesterone for the indication of endometrial protection in women on hormone replacement therapy as of the 2026 formulary cycle. This is a narrow coverage exclusion tied specifically to the HRT indication, not a blanket progesterone exclusion.

What Centennial Care Does Cover

Centennial Care may cover progesterone formulations for other indications such as threatened preterm labor (intramuscular 17-OHPC) or secondary amenorrhea when prior authorization criteria are met. Coverage decisions follow the New Mexico Human Services Department pharmacy benefit manager formulary, which is updated quarterly. Patients should request a formulary exception in writing if a prescribing clinician documents medical necessity.

Appealing a Medicaid Denial

Federal Medicaid rules require that every state provide a formal appeals process. New Mexico enrollees have 90 days from a denial notice to file an appeal with Centennial Care. A board-certified gynecologist or endocrinologist writing a letter of medical necessity documenting symptomatic menopause and the clinical need for concurrent progestogen has a reasonable chance of obtaining coverage on appeal, particularly when the alternative (unopposed estrogen in women with an intact uterus) carries a documented risk of endometrial hyperplasia supported by the PEPI trial data. The PEPI Trial (JAMA, 1995; N=875) showed that unopposed conjugated equine estrogen produced endometrial hyperplasia in 62% of participants at three years versus under 1% with micronized progesterone.

Is Compounded Progesterone Legal in New Mexico?

Yes. Compounded oral micronized progesterone is legal in New Mexico when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription from a licensed prescriber. This is distinct from 503B outsourcing facilities, which compound in bulk without patient-specific orders.

503A vs. 503B: What New Mexico Patients Need to Know

Under the federal Drug Quality and Security Act (DQSA) of 2013, 503A pharmacies must compound only in response to a valid prescription and may not make copies of commercially available drugs unless a patient has a documented allergy or intolerance. The FDA's overview of 503A compounding requirements is maintained here. New Mexico's Board of Pharmacy enforces these federal standards alongside state-specific compounding rules. A 503A-compounded progesterone capsule typically costs $25 per month, compared to $45 or more at retail for a generic commercial product.

When Compounded Progesterone Makes Clinical Sense

Compounding is most appropriate when a patient has a documented sensitivity to peanut oil (the excipient in Prometrium and most generics) or requires a non-standard dose such as 50 mg, 75 mg, or 150 mg that is not commercially available. The Endocrine Society's 2022 clinical practice guideline on menopause management notes that micronized progesterone is preferred over synthetic progestogens for its more favorable cardiovascular and sleep profiles. Patients seeking compounded formulations should verify their pharmacy holds a current New Mexico Board of Pharmacy compounding license, which is publicly searchable.

Peanut Allergy and Alternative Excipients

Patients with confirmed peanut allergy should not use standard Prometrium or most generic oral micronized progesterone capsules. A 503A compounding pharmacy can prepare progesterone in alternative oil bases such as sunflower or olive oil at the prescriber's request. This is one of the most clinically valid reasons to use a compounded product in New Mexico even when the commercial generic is available.

Which Insurance Plans Cover Oral Micronized Progesterone in New Mexico?

Most commercial insurance plans sold in New Mexico through the Blue Cross Blue Shield of New Mexico, Presbyterian Health Plan, and Molina Healthcare marketplace networks include oral micronized progesterone on their formularies, typically on Tier 2 or Tier 3. Tier placement affects your copay directly.

Tier Placement and What It Means for Your Copay

A Tier 2 placement typically means a $15 to $45 branded copay or $5 to $20 generic copay per 30-day fill, depending on the plan's benefit design. A Tier 3 placement, which is more common for brand Prometrium, can mean $50 to $120 per fill without hitting your deductible first. If your plan places generic progesterone on Tier 1 (preferred generic), you may pay as little as $0 to $10 per month. The ACA requires most non-grandfathered plans to cover FDA-approved contraceptive and preventive services without cost sharing, though progesterone for HRT falls outside that specific mandate.

Medicare Part D in New Mexico

Medicare Part D plans vary by carrier. As of 2026, generic oral micronized progesterone appears on the formularies of several Part D plans available in New Mexico, including plans offered by Humana, UnitedHealthcare, and Cigna-HealthSpring. The Inflation Reduction Act 2023 amendments cap out-of-pocket drug costs for Part D beneficiaries, which benefits patients on continuous HRT. CMS data on Part D formulary requirements are published at cms.gov.

Requesting a Tier Exception

When your insurer places oral micronized progesterone on a higher tier, you can submit a tier exception request supported by a clinician letter explaining why the branded or non-preferred version is medically necessary, or alternatively why the preferred alternative is inappropriate. Approval rates for tier exceptions improve significantly when the letter cites specific clinical evidence and patient history.

Can You Get Oral Micronized Progesterone via Telehealth in New Mexico?

Telehealth prescribing of oral micronized progesterone is fully legal in New Mexico in 2026. The state allows prescribers licensed in New Mexico to evaluate and treat patients via synchronous audio-video telehealth and to transmit controlled and non-controlled prescriptions electronically to any licensed in-state pharmacy. Progesterone is not a controlled substance, which simplifies the telehealth prescribing pathway considerably.

What a Telehealth Visit for Progesterone Involves

A qualifying telehealth visit for HRT including oral micronized progesterone typically involves a review of menopausal symptom history, last menstrual period, uterine status (intact uterus vs. Post-hysterectomy), current estrogen regimen if applicable, and baseline cardiovascular and breast cancer risk screening. The Menopause Society (formerly NAMS) 2023 position statement on menopause hormone therapy indicates that progestogen addition is required in all women with an intact uterus receiving systemic estrogen.

Most HealthRX telehealth visits for hormonal evaluation take 20 to 30 minutes. The prescriber reviews labs ordered in advance or ordered at a local Quest or LabCorp draw site near Albuquerque, Santa Fe, or Taos, then transmits the prescription electronically.

Prescription Sent Directly to Your New Mexico Pharmacy

Once prescribed, the electronic prescription goes directly to your chosen New Mexico retail pharmacy or to a licensed 503A compounding pharmacy if a compounded formulation is appropriate. Mail-order pharmacy options through your insurance plan may reduce cost to a 90-day supply copay, often cheaper per day than 30-day retail fills.

What Is the Cheapest Way to Get Oral Micronized Progesterone in New Mexico?

The lowest-cost path depends on your insurance status. For uninsured or underinsured patients, a licensed New Mexico 503A compounding pharmacy with a valid prescription offers the lowest price at roughly $25 per month, assuming no peanut allergy requiring a premium alternative excipient. For patients with commercial insurance, verifying that your plan covers generic progesterone on Tier 1 or Tier 2 and using a 90-day mail-order fill reduces per-dose cost.

Step-by-Step Cost Minimization for NM Residents

1. Ask your prescriber to write for generic oral micronized progesterone 100 mg (or 200 mg if cyclic) rather than brand Prometrium.
2. Run the prescription through GoodRx, RxSaver, or Blink Health before filling to compare prices at every pharmacy within your zip code.
3. If the GoodRx cash price exceeds $30/month, ask your clinician whether a 503A compounded version is clinically appropriate for your situation.
4. If you have commercial insurance, call member services and ask for the Tier 1 or Tier 2 generic progesterone copay amount before filling.
5. If you have Medicare Part D, use the Medicare Plan Finder tool at Medicare.gov to compare formulary tiers across 2026 Part D plans in your New Mexico county during open enrollment.

Manufacturer Patient Assistance

Abbvie's myAbbVie Assist program provides brand Prometrium at no cost to patients who meet income eligibility criteria (generally household income at or below 400% of the federal poverty level and no insurance coverage for the drug). Applications are submitted through the prescribing clinician's office. Processing takes 2 to 4 weeks for initial approval. NeedyMeds.org maintains a current listing of patient assistance programs for progesterone products.

Clinical Background: Why Oral Micronized Progesterone Is Prescribed

Oral micronized progesterone is prescribed to women with an intact uterus who are taking systemic estrogen therapy because unopposed estrogen increases the risk of endometrial hyperplasia and carcinoma. The evidence for this comes from several well-designed trials and is reflected in current guidelines.

PEPI Trial Evidence

The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial, published in JAMA in 1995 (N=875), remains a cornerstone reference. That trial demonstrated that micronized progesterone 200 mg/day cyclic produced the most favorable high-density lipoprotein cholesterol profile among all progestogen regimens tested, while fully protecting the endometrium. The synthetic progestin medroxyprogesterone acetate (MPA) blunted the estrogen-associated HDL-C rise, while micronized progesterone did not. This cardiovascular distinction continues to influence prescriber preference for oral micronized progesterone over MPA in 2026.

Sleep and Neurosteroid Effects

Oral micronized progesterone is metabolized to allopregnanolone, a potent positive allosteric modulator of GABA-A receptors. Research published in Menopause (2018) found that 300 mg nightly oral micronized progesterone improved objective sleep efficiency in postmenopausal women over a 3-week period. This sedating effect is why oral micronized progesterone is almost always dosed at bedtime rather than in the morning. Prescribers in New Mexico who treat patients with concurrent insomnia and menopausal symptoms sometimes view this as a clinical advantage over vaginal or transdermal progestogen routes.

Breast Safety Profile

The E3N-EPIC cohort study (N=80,377 French women, Fournier et al.) found a lower relative risk of breast cancer associated with micronized progesterone combined with estradiol compared to synthetic progestins combined with estrogen. That finding is summarized in a 2008 Breast Cancer Research and Treatment publication. These data, while observational and not from a randomized controlled trial, contributed to the shift in European and North American prescribing toward micronized progesterone as the preferred progestogen for HRT.

Current Dosing in Clinical Practice

The FDA-approved dosing for endometrial protection is 200 mg orally every night for 12 days per 28-day cycle (cyclic regimen) or 100 mg every night continuously. The Menopause Society 2023 position statement specifies that both regimens are acceptable and that continuous combined therapy may reduce cyclic bleeding in postmenopausal women. Prescribers at HealthRX individualize regimen selection based on time since last menstrual period, patient preference regarding bleeding, and whether the patient is perimenopausal or fully postmenopausal.

Are There New Mexico-Specific Discount Programs for Oral Micronized Progesterone?

New Mexico does not operate a state-funded pharmaceutical assistance program specifically for oral micronized progesterone as of 2026. However, several overlapping resources reduce cost for eligible residents.

New Mexico Rx (State PAP Program)

The New Mexico Human Services Department administers a limited pharmaceutical assistance program for residents above Medicaid income limits but below a defined threshold. Information on eligibility and enrollment is published by the New Mexico Human Services Department. As of 2026, oral micronized progesterone is not listed among the covered drugs in this program, but formulary updates occur annually and patients should check current listings.

Federally Qualified Health Centers in New Mexico

Patients without insurance who live near a Federally Qualified Health Center (FQHC) may access sliding-scale prescription services through the 340B drug pricing program. The Health Resources and Services Administration (HRSA) maintains a locator for 340B-eligible FQHCs. FQHCs in Albuquerque, Santa Fe, Gallup, and Farmington participate in 340B, and progesterone prescriptions filled through these centers may cost significantly less than retail pharmacy prices.

Indian Health Service

Enrolled members of New Mexico's federally recognized tribes may access oral micronized progesterone through the Indian Health Service (IHS) pharmacy benefit at no direct cost, subject to formulary availability at the specific IHS facility. The IHS pharmacy program information is published at ihs.gov.

How Does the Prometrium Savings Card Work in New Mexico?

The Abbvie savings card for Prometrium applies to commercially insured patients in New Mexico and reduces the out-of-pocket copay at the pharmacy counter. It does not apply to patients with Medicaid, Medicare, TRICARE, or any other federally funded insurance program.

Mechanics of the Card

At the pharmacy, the pharmacist runs two claims simultaneously: the primary insurance claim and the savings card claim as a secondary payer. The savings card covers the gap between what insurance pays and what the patient owes, up to a published annual maximum (typically $3,600 per calendar year as of recent program years). New Mexico pharmacies with electronic secondary billing capability process this automatically. Abbvie's patient assistance and savings program details are accessible through their patient support portal.

When the Savings Card Does Not Help

If your plan places Prometrium on a specialty or non-formulary tier with a coinsurance rather than a flat copay, the savings card may not cover the full balance above the annual cap. In that scenario, switching to a generic oral micronized progesterone product and using a GoodRx coupon often produces a lower total cost even without the manufacturer card. The price difference between brand and generic at New Mexico pharmacies averages $120 to $135 per month before any assistance.